Literature DB >> 11870942

Transradial coronary brachytherapy with the Novoste Beta-Rail system.

Olivier F Bertrand1, Robert De Larochellière, Onil Gleeton, Sylvain Plante, Michel Tessier, Jean Guimond.   

Abstract

We report our initial experience in 10 consecutive patients who underwent transradial coronary brachytherapy for in-stent restenosis using a 90Sr/Y source and the Novoste Beta-Rail system. In all patients, procedures were successfully completed using a right transradial approach. We performed the procedures with the Beta-Rail catheter using 7 Fr (Zuma II, Medtronic, MN; n = 5) or 8 Fr (Cordis, Miami, FL; n = 5) guiding catheters. All lesions were successfully dilated and no additional stent was inserted. We used a 40 mm source (n = 3) or a 60 mm source (n = 7) with manual stepping in four cases. In three cases, we did one stepping, and in one case, we did three steppings. The mean dwell time was 195 plus minus 44 sec. The mean delivered dose was 23 +/- 3 Gy at 2 mm distance from the source. No radiation treatment was interrupted. Mean fluoroscopy time was 26 +/- 13 min. Procedural success was achieved in all patients. Three patients had mild CK elevations (< 3 times upper normal limit). All patients were pretreated with clopidogrel (300 mg) and combined treatment with aspirin + clopidogrel is to be continued for at least 1 year. Clinical follow-up up to 3 months has not yielded any complication and all patients have remained free from angina. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870942     DOI: 10.1002/ccd.10083

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  1 in total

Review 1.  Outpatient percutaneous coronary intervention: Ready for prime time?

Authors:  Olivier F Bertrand; Eric Larose; Robert De Larochellière; Guy Proulx; Can Manh Nguyen; Jean-Pierre Déry; Onil Gleeton; Gérald Barbeau; Bernard Noël; Jacques Rouleau; Jean-Roch Boudreault; Louis Roy; Josep Rodés-Cabau
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.